AI-generated summary
This review surveys transcranial photobiomodulation (tPBM), a light-based approach for brain diseases, drawing on over one hundred references from the past 20 years. The authors report that tPBM has been used in pre-clinical and clinical studies for conditions such as stroke and Alzheimer's disease, and they discuss its advantages and disadvantages. They also note that understanding its mechanisms, developing clinical guidelines, and studying dose-dependent and personal effects remain important for future progress.
- Who or what was studied
- Brain diseases, including stroke and Alzheimer's disease, studied in animal and human research
- Limits stated in the abstract
- The abstract does not state the number of included studies, and it describes the review's aims rather than quantified findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The brain diseases account for 30% of all known diseases. Pharmacological treatment is hampered by the blood-brain barrier, limiting drug delivery to the central nervous system (CNS). Transcranial photobiomodulation (tPBM) is a promising technology for treating brain diseases, due to its effectiveness, non-invasiveness, and affordability. tPBM has been widely used in pre-clinical experiments and clinical trials for treating brain diseases, such as stroke and Alzheimer's disease. This review provides a comprehensive overview of tPBM. We summarize emerging trends and new discoveries in tPBM based on over one hundred references published in the past 20 years. We discuss the advantages and disadvantages of tPBM and highlight successful experimental and clinical protocols for treating various brain diseases. A better understanding of tPBM mechanisms, the development of guidelines for clinical practice, and the study of dose-dependent and personal effects hold great promise for progress in treating brain diseases.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Stroke, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.